Please select the option that best describes you:

In patients with high-risk polycythemia vera with a history of thrombosis, should aspirin be used in addition to indefinite anticoagulation and cytoreduction for prevention of recurrent thrombosis?   

What if there are no cardiovascular risk factors?  Are VKAs preferred or can DOACs be used?



Answer from: Medical Oncologist at Community Practice
Comments
at UT Southwestern Medical Center
Thank you for your time and expertise, Dr. @Aaron ...
Sign in or Register to read more